I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Schreeder, Marshall
31
results:
Search for persons
X
Format
Online (31)
Mediatypes
Articles (Online) (23)
OpenAccess-fulltext (8)
Sorted by: Relevance
Sorted by: Year
?
1
P2.06-017 Amethyst NSCLC Trial: Phase 2 Study of MGCD265 in..:
Bazhenova, Lyudmila
;
Kim, Dong-Wan
;
Cavanna, Luigi
...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S1080-S1081 , 2017
Link:
https://doi.org/10.1016/..
?
2
Randomized controlled trial of irinotecan drug‐eluting bead..:
Martin II, Robert C. G.
;
Scoggins, Charles R.
;
Schreeder, Marshall
...
Cancer. 121 (2015) 20 - p. 3649-3658 , 2015
Link:
https://doi.org/10.1002/..
?
3
Irinotecan Drug-Eluting Beads in the Treatment of Chemo-Nai..:
Martin II, Robert C.G.
;
Scoggins, Charles R.
;
Tomalty, Dana
...
Journal of Gastrointestinal Surgery. 16 (2012) 8 - p. 1531-1538 , 2012
Link:
https://doi.org/10.1007/..
?
4
Weekly treatment with bortezomib for patients with recurren..:
Hainsworth, John D.
;
Spigel, David R.
;
Barton, John
...
Cancer. 113 (2008) 4 - p. 765-771 , 2008
Link:
https://doi.org/10.1002/..
?
5
Phase I-II Study of Cisplatin, VP-16, MGBG, Mitomycin, and ..:
Christian, Elizabeth S.
;
Schreeder, Marshall
;
Salter, Merle M.
...
American Journal of Clinical Oncology. 11 (1988) 4 - p. 502-505 , 1988
Link:
https://doi.org/10.1097/..
?
6
Idelalisib in Combination With Rituximab or Bendamustine or..:
Coutre, Steven E.
;
Flinn, Ian W.
;
de Vos, Sven
...
HemaSphere. 2 (2018) 3 - p. , 2018
Link:
https://doi.org/10.1097/..
?
7
A phase 1/2 trial of ublituximab, a novel anti-CD20 monoclo..:
Sawas, Ahmed
;
Farber, Charles M.
;
Schreeder, Marshall T.
...
British Journal of Haematology. 177 (2017) 2 - p. 243-253 , 2017
Link:
https://doi.org/10.1111/..
?
8
Combinations of idelalisib with rituximab and/or bendamusti..:
de Vos, Sven
;
Wagner-Johnston, Nina D.
;
Coutre, Steven E.
...
Blood Advances. 1 (2016) 2 - p. 122-131 , 2016
Link:
https://doi.org/10.1182/..
?
9
Ublituximab (TG‐1101), a novel glycoengineered anti‐CD20 an..:
Sharman, Jeff P.
;
Farber, Charles M.
;
Mahadevan, Daruka
...
British Journal of Haematology. 176 (2016) 3 - p. 412-420 , 2016
Link:
https://doi.org/10.1111/..
?
10
Randomized phase II study of carboplatin and etoposide with..:
Langer, Corey J.
;
Albert, Istvan
;
Ross, Helen J.
...
Lung Cancer. 85 (2014) 3 - p. 420-428 , 2014
Link:
https://doi.org/10.1016/..
?
11
5.43 Patterns of Nodal Response and Lymphocytosis in Patien..:
Brown, Jennifer R.
;
Jahn, Thomas M.
;
Furman, Richard R.
...
Clinical Lymphoma Myeloma and Leukemia. 11 (2011) - p. S272-S274 , 2011
Link:
https://doi.org/10.1016/..
?
12
The expression of TRMT2A, a novel cell cycle regulated prot..:
Hicks, David G
;
Janarthanan, Bagi R
;
Vardarajan, Ramya
...
BMC Cancer. 10 (2010) 1 - p. , 2010
Link:
https://doi.org/10.1186/..
?
13
A novel five-antibody immunohistochemical test for subclass..:
Ring, Brian Z
;
Seitz, Robert S
;
Beck, Rodney A
...
Modern Pathology. 22 (2009) 8 - p. 1032-1043 , 2009
Link:
https://doi.org/10.1038/..
?
14
TLE3 as a candidate biomarker of response to taxane therapy:
Kulkarni, Swati A
;
Hicks, David G
;
Watroba, Nancy L
...
Breast Cancer Research. 11 (2009) 2 - p. , 2009
Link:
https://doi.org/10.1186/..
?
15
Cetuximab in combination with carboplatin and docetaxel for..:
Belani, Chandra P.
;
Schreeder, Marshall T.
;
Steis, Ronald G.
...
Cancer. 113 (2008) 9 - p. 2512-2517 , 2008
Link:
https://doi.org/10.1002/..
1-15